PDT Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,327	Closed	-$205K	–	680
2025 Q1	$205K	Buy	12,327 +1	+0%	+$18	0.01%	672
2024 Q4	$226K	Sell	12,326 -892	-7%	-$14.4K	0.02%	635
2024 Q3	$203K	Buy	+13,218	New	+$221K	0.02%	658
2024 Q1	–	Sell	-13,599	Closed	-$426K	–	617
2023 Q4	$426K	Sell	13,599 -27,160	-67%	-$649K	0.05%	426
2023 Q3	$849K	Sell	40,759 -56,746	-58%	-$1.54M	0.11%	323
2023 Q2	$2.34M	Sell	97,505 -69,490	-42%	-$1.54M	0.32%	94
2023 Q1	$3.14M	Buy	166,995 +137,309	+463%	+$2.62M	0.43%	63
2022 Q4	$473K	Buy	29,686 +6,400	+27%	+$100K	0.08%	401
2022 Q3	$381K	Sell	23,286 -63,722	-73%	-$1.03M	0.06%	513
2022 Q2	$1.23M	Sell	87,008 -157,817	-64%	-$2.95M	0.11%	321
2022 Q1	$5.93M	Buy	244,825 +55,697	+29%	+$1.35M	0.51%	17
2021 Q4	$4.41M	Sell	189,128 -34,002	-15%	-$684K	0.34%	77
2021 Q3	$3.71M	Buy	223,130 +173,130	+346%	+$3.34M	0.27%	175
2021 Q2	$1.22M	Buy	+50,000	New	+$1.13M	0.08%	337
2018 Q4	–	Sell	-512,358	Closed	-$10.6M	–	458
2018 Q3	$10.6M	Sell	512,358 -169,142	-25%	-$2.66M	0.44%	62
2018 Q2	$10.4M	Buy	681,500 +70,800	+12%	+$1.26M	0.4%	79
2018 Q1	$13.7M	Buy	+610,700	New	+$16.9M	0.46%	66
2016 Q1	–	Sell	-120,771	Closed	-$4.3M	–	557
2015 Q4	$4.3M	Buy	120,771 +69,340	+135%	+$2.44M	0.59%	28
2015 Q3	$1.7M	Sell	51,431 -100,421	-66%	-$4.18M	0.04%	520
2015 Q2	$6.36M	Buy	+151,852	New	+$5.88M	0.17%	143